Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q57571900)
Watch
English
The coming of age of MEK
scientific article published on 16 July 2012
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22805290
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22805290%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
title
The coming of age of MEK
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22805290
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22805290%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
author
Grant McArthur
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22805290
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22805290%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
publication date
16 July 2012
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22805290
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22805290%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
published in
Lancet Oncology Commission
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22805290
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22805290%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
volume
13
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22805290
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22805290%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
issue
8
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22805290
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22805290%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
page(s)
744-745
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22805290
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22805290%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
cites work
BRAF mutation predicts sensitivity to MEK inhibition
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970317-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970317-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
RAS oncogenes: the first 30 years.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970317-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970317-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970317-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970317-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
GSK1120212 (JTP-74057) is an inhibitor of MEK activity and activation with favorable pharmacokinetic properties for sustained in vivo pathway inhibition
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970317-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970317-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970317-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1470-2045(12)70317-0
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22805290
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22805290%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
PubMed publication ID
22805290
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22805290
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22805290%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit